Several studies have applied multiplexing methods to examine the EOC TiME and have reported differing patterns of tumor-infiltrating lymphocytes, as well as associations between CD47 expression on different immune cells and survival parameters, and associations between the distribution of immune cell phenotypes and survival or response to combined therapy with poly-ADP-ribose polymerase and immune checkpoint inhibitors [44,45,49,50]. Here, CD47 is linked to neoplasm.